The Dela Cruz laboratory focuses on two main research programs: (1) Studying novel immune regulators in the lung during respiratory infections, and (2) Studying the effects of cigarette smoke (CS) exposure in the pathogenesis of airway and lung diseases such as chronic obstructive pulmonary disease (COPD) using preclinical genetic mouse models and human biosamples.
The Dela Cruz laboratory focuses on two main research programs: (1) Studying novel immune regulators in the lung during respiratory infections, and (2) Studying the effects of cigarette smoke (CS) exposure in the pathogenesis of airway and lung diseases such as chronic obstructive pulmonary disease (COPD) using preclinical genetic mouse models and human biosamples. The goal of the lab is also to be able to confirm and translate the findings using biospecimens from the established and establishing cohort of human patients with various lung diseases.